Sundhedsstyrelsens nye retningslinier - DSOG

Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. Human papillomavirus
type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis
update. Int J Cancer 2007;121:621-32.
6
zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev
Cancer 2002;2:342-50.
7
Bosch A. Lorincz N. Munoz CJL, Meijer M, Shah KV. The causal relation between human papillomavirus
and cervial cancer. J Clin Pathol 2002;55:244-65.
8
Clifford G, Franceshi S, Diaz M, Munoz N, Villa LL, Chapter 3: HPV type-distribution in women
with and without cercical neoplastic diseases. Vaccine 2006;24: S26-S34.
9
Montag M, Blankenstein TJ, Shabani N, Brüning A, Mylonas I. Arch Gynecol Obstet 2010; Nov
27 [Epub ahead of print].
10
Molden T, Kraus I, Skomedal H, Nordstrøm T, Karsen F. Pretect HPV-Proofer: real-time detection
and typing of E6/E7 mRNA from carcionogenic human papillomavirus. J Virol Methods
2007;142:204-12.
11
Snijders PJ, Meijer CJ, Walboomers JM. Degenerate primers based on highly conserved regions of
amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to
detect productive human papillomavirus infection. J Gen Virol 1991;72:2781-6.
12
Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. Population-based prevalence,
type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination
program in Denmark. Int J Cancer 2008; 123:1864-1870.
13
zur Hausen H. Papilloma viruses and cancer: from basic studies to clinical application. Nature Publishing
Group 2005;2:342-50.
14
Szarewski A, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, Mc Carthy J,
Buckley H, Bergeron C, Soutter P, Lyons D, Cizick J. Comparison of predictors for high-grade
cervical intraepitelial neoplasia in women with abnormal smears Cancer. Cancer Epidem Biomar
2008;17:3033-42.
15
Denton KJ, Bergeron C, Klement P, Trunk MJ, Keller T, Ridder R (European CINtec Cytology
Study Group). The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting
high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results. Am J Clin
Pathol 2010;134:12-21.
16
Lorincz A. Hybrid Capture method for detection of human papillomavirus DNS in clinical specimens:
a tool for clinical management of equivocal Pap smears and for population screening. J Obstet
Gynaecol Res 1996;22:629-36.
17
Screening for livmoderhalskkræft. Anbefalinger 2011
77